The Rundown: ExL’s Blog
Viewing 11 to 20 of 53 records.
Just Announced: The 7th CROWN Congress, January 23–25, 2018 at the Westin Philadelphia
Thursday July 27th, 2017
The 7th Annual CROWN Congress will be held on January 23–25, 2018 at the Westin Philadelphia, ExL Events is happy to announce. This intimate summit attracts leading experts, forward-thinking visionaries, and senior-level executives and offers an interactive forum to discuss the forces changing the industry and how clinical operations must adapt to succeed. With well over half of the audience representing pharmaceutical, biotechnology and medical device companies and an even split between those focused on clinical operations, outsourcing, and quality, it’s the perfect balance of perspectives making…
FDA Head & Former ExL Speaker, Dr. Scott Gottlieb, Takes to Twitter With Clear Stance on Vaccines
Monday July 24th, 2017
Recently sworn-in commissioner of the Food and Drug Administration (FDA) Dr. Scott Gottlieb has affirmed his stance on the vaccination debate in many instances, but a recent Twitter post is sure to make his intentions on the matter perfectly clear. Unlike the man who appointed him to his position, President Donald Trump, toes the line of anti-vaccine and pro-vaccine, Gottlieb is embracing his new status to spread scientific data and other newsworthy tidbits on the matter.
In a message to his followers, Dr. Gottlieb shared an infographic the country before and…
Featured Speakers: 5th Promotional Review Committee Compliance & Best Practices
Thursday July 13th, 2017
ExL Events is hosting the 5th Annual Promotional Review Committee Compliance & Best Practices conference on October 16–17, 2017 at the Wyndham Hamilton Park in Florham Park, NJ. Here, we take a look at the conference’s impressive list of featured speakers!
Cynthia Akue, Promotional Planner, ALLERGAN
Sergio Alegre, Vice President, Global Compliance, VERTICAL PHARMACEUTICALS
Jill Charbonneau, Director, Regulatory Affairs, AdProm, Product Launch and Labeling, MARATHON PHARMACEUTICALS
Masha Chestukhin, Senior Manager, North America Compliance, SANOFI
Howard Dorfman, Senior Corporate Counsel, EDGE THERAPEUTICS
David Jacobs, Assistant General Counsel, Commercial Brands, DAIICHI SANKYO
Sameer Lal, Senior Vice President,…
4 Worrisome Issues About Working With Social Media Influencers
Monday July 10th, 2017
Social media influencers have made their way into the pharma industry and embracing this new marketing strategy in your company is a no-brainer. But with new avenues comes other issues to look out for so that your message doesn’t turn into something that can hurt your business. Here, we take a look at four worrisome issues about working with social media influencers in the world of life sciences, medicine and more.
When considering the possible benefits for your company of reaching out to an influencer, you should take these issues into consideration.
Genuineness: Like any contractor brought into the…
Hashtags, Digital Marketing, and Medical Issues
Wednesday July 5th, 2017
Capitalizing on new social media strategies is imperative for every industry, but with spreading the word regarding medical issues the subject matter can be dire. In the life sciences and medical industries, digital marketing plays a huge role in advancing one’s company in an ever-evolving landscape and can determine said organization’s relevance to consumers. In today’s blog post, we’re taking a look at digital marketing’s easiest and arguably most crucial practice: hashtags. Are you implementing the hashtag (#) the best you can? What practices should one follow when using hashtags? Let’s take a look together!
Hashtags make Twitter and other…
The Top 10 Diabetes Drugs by Sales
Thursday June 29th, 2017
If you’re reading this post, you’re likely involved in the world of diabetes in some way — either as a patient yourself or as a supporter of a loved one that is diabetic. What drugs have you used to treat diabetes in your life? You could have that medicine/treatment in common with others affected by diabetes. Just below, FiercePharma has compiled the 2016 sales rankings of diabetes drugs, based on data from EvaluatePharma. The following graphic breaks down this information by drug class, drug name, pharmaceutical company, and sales, all compiled into an easy-to-understand…
Just Announced: The First and Only Life Science Investor Relations Forum
Thursday June 22nd, 2017
ExL Events has just announced the industry’s first annual Life Science Investor Relations Forum, hosted on September 7–8, 2017 in Boston, MA. This inaugural event will bring together investor relations professionals to address the diverse set of challenges faced in the life science industry. We’ve assembled an expert speaking faculty who will provide two content-packed days of thought-provoking dialogue. This engaging and informative event will also offer ample networking time for IR professionals.
“We’re excited about this conference. We’ve had professionals tell…
Pfizer Executive Previews the 8th Clinical Quality Oversight Forum in New Interview
Sunday June 18th, 2017
One of our esteemed faculty speakers recently sat down with AppliedClinicalTrialsOnline.com to discuss clinical trial quality events, which of course led to some greatly appreciated ExL conference previews! The subject of this interview is Dr. Jonathan Rowe, Executive Director and Head of Clinical Development Quality Performance and Risk Management, at Pfizer. Jonathan is speaking at our 8th Clinical Quality Oversight Forum and touches on his upcoming session in the interview.
Rowe, who recently spoke at ExL’s CROWN Congress, also answers questions regarding Pfizer’s tactics for managing clinical trial…
13th Pharmaceutical Meeting Professionals Summit to Be Held November 6–7, 2017 at the Hilton Philadelphia at Penn’s Landing
Thursday June 15th, 2017
The 13th Pharmaceutical Meeting Professionals Summit will be held on November 6–7, 2017 at the Hilton Philadelphia at Penn’s Landing. This interactive summit attracts 200+ senior-level meeting professionals working in the pharmaceutical, biotechnology, and medical device industries, and acts as their annual gathering to learn, engage, and network.
With well over 60% of the 2016 audience representing meeting planners and with 57% of them having more than 10 years of experience in the events industry, this is the ideal forum to learn from and meet with industry veterans to understand current trends, innovation and efficient strategies for optimizing medical meeting…
GSK Acquires PRV for ViiV’s Two-Drug HIV Therapy, Beating Gilead to Billion-Dollar Market
Thursday June 8th, 2017
Late last week, ViiV Healthcare filed applications with both the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) for the world’s first two-drug HIV maintenance therapy. The treatment will also be the first of its kind on the market thanks to a surprising priority review voucher (PRV) acquisition by ViiV’s majority owner, GlaxoSmithKline – capitalizing on the multi-billion-dollar HIV market four months earlier than competitors Gilead’s HIV treatment.
Instead of the usual 10-month application process, this PRV allows ViiV, and therefore GSK, to have it completed in six months. For more information on PRVs, check out…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs